ReviewNature reviews. Drug discovery2011
The discovery and development of rivaroxaban, an oral, direct factor Xa inhibitor.
Elisabeth Perzborn et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
94 papers cite itlatest 60 shown
this paperpooled ittrialcites it